Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ChemoCentryx
Pharma
Tavneos patient starts resume in Japan amid safety scrutiny
Doctors in Japan can once again prescribe Amgen’s Tavneos to new patients, albeit with revised safety precautions tucked into the product packaging.
Fraiser Kansteiner
May 21, 2026 11:38am
FDA takes first steps in withdrawing approval of Amgen's Tavneos
Apr 28, 2026 11:37am
With trial data in question, FDA asks Amgen to ground Tavneos
Feb 4, 2026 7:55am
Amgen's ChemoCentryx prevails in investor lawsuit
Aug 19, 2025 10:13am
Lawsuit points to alleged misconduct at Amgen-bought biotech
Jul 25, 2025 11:18am
ATyr hires ex-ChemoCentryx commercial chief for planned launch
Mar 26, 2025 12:59pm
